Klaria Receives Third Payment from the EU Horizon 2020 Program Supporting the Development of the Sumatriptan Alginate Film
Klaria reports that it has successfully performed and reported the planned activities under the ongoing European Commission Horizon 2020 Innovation Grant (Grant Number 8296159). The third payment, totaling ca. 2 million SEK has now been confirmed by the EU. Klaria has thus far received approximately 18,5 million SEK of the total 21 million SEK specified in the grant agreement. The project will end on June 30[th] of this year and Klaria anticipates receiving the full remaining balance upon successful completion of the final report to the EU.The Horizon 2020 program supporting the